is the Vaccine s business of Sanofi-aventis Group. It is the largest company in the world devoted entirely to vaccines.
In 2004, Aventis merged with and into Sanofi. The new Sanofi-aventis Group become the world's 3rd largest pharmaceutical company, ranking number 1 in Europe. Aventis Pasteur, the vaccine division of sanofi-aventis Group, changes its name to sanofi pasteur.
- 1897, Marcel Mérieux creates the Mérieux Biological Institute in Lyon. Richard Slee creates the Pocono Biological Laboratories, in Swiftwater (Pennsylvania) in the US
- 1914, John FitzGerald creates Connaught Laboratories, part of the University of Toronto.
- 1968, Rhône-Poulenc acquires 51% of the capital of the Institut Mérieux.
- 1974, Pasteur Institute creates Pasteur Production, a subsidiary specializing in manufacturing vaccines
- 1978, Connaught Laboratories in Canada acquires the Salk Institute's laboratories at Swiftwater, Pennsylvania, in the US.
- 1985, Pasteur Production, the vaccines branch of the Institut Pasteur, is acquired by the Mérieux Institute, and Pasteur Vaccins is created
- 1989, The Mérieux Institute acquires the Connaught Laboratories in Canada and its subsidiaries and becomes a world leader in human biology
- 1990, Creation of Pasteur Mérieux Serums & Vaccins
- 1994, Pasteur Mérieux Sérums & Vaccins becomes a wholly owned subsidiary of Rhône-Poulenc.
- 1996, Pasteur Mérieux Connaught is the new name of Pasteur Mérieux Serums et Vaccins
- 1999, Rhône-Poulenc and Hoechst unite their Life Sciences activities in a single company, which takes on the name Aventis. Within this group, Pasteur Mérieux Connaught changes its name to Aventis Pasteur.
- 2004, merger of Aventis with and into Sanofi. The new sanofi-aventis Group becomes the world's 3rd largest pharmaceutical company, ranking number 1 in Europe. Aventis Pasteur, the vaccine division of the sanofi-aventis Group, changes its name to sanofi pasteur.
- Sanofi pasteur - proforma sales: € 1.624 billion (growth of 7.5%)
- Staff: over 9,000 employees
- Nearly a billion doses of vaccines sold to protect over 500 million people in the world
- A wide range of vaccines protecting against 20 bacterial and viral diseases
- A presence in 150 countries
- R&D: 17% of sales reinvested in R&D, over 1,000 persons working in France, U.S.A. and Canada
- Headquarters: Lyon, France
- TheraCys ®, Bladder Cancer
- ADACEL ™, Diphtheria , Tetanus and Pertussis
- DAPTACEL ® (DTaP), Diphtheria , Tetanus and Pertussis
- Diphtheria And Tetanus Toxoids Adsorbed USP , Diphtheria , Tetanus and Pertussis
- Tetanus Toxoid Adsorbed , Diphtheria , Tetanus and Pertussis
- TriHIBit ®, Diphtheria , Tetanus and Pertussis
- Tripedia ®, Diphtheria , Tetanus and Pertussis
- ActHIB ®, Haemophilus Influenza Type B
- Fluzone ®, Influenza Virus Vaccine]], Influenza
- Menactra ®, Meningococcal Vaccines
- Menomune ®-A/C/Y/W-135, Meningococcal Vaccines
- IPOL ®, Polio
- Imogam ® Rabies-HT, Rabies
- IMOVAX ® RABIES, Rabies
- DECAVAC ®, Tetanus
- Tetanus Toxoid For Booster Use Only , Tetanus
- JE-VAX ®, Japanese Encephalitis Virus Vaccine
- Typhim Vi ®, Typhoid Vi Polysaccharide Vaccine
- YF-VAX ®, Yellow Fever Vaccine
- Tubersol ®, Tubercolosis
|
